|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y, Shi J, Huang H, Ren J, Li N and
Dai M: Burden of colorectal cancer in China. Zhonghua Liu Xing Bing
Xue Za Zhi. 36:709–714. 2015.(In Chinese). PubMed/NCBI
|
|
3
|
Brenner H, Stock C and Hoffmeister M:
Colorectal cancer screening: The time to act is now. BMC Med.
13:2622015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zoni E, van der Pluijm G, Gray PC and
Kruithof-de Julio M: Epithelial plasticity in cancer: Unmasking a
microRNA network for TGF-beta-, notch-, and Wnt-mediated EMT. J
Oncol. 2015:1989672015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kohlhapp FJ, Mitra AK, Lengyel E and Peter
ME: MicroRNAs as mediators and communicators between cancer cells
and the tumor microenvironment. Oncogene. 34:5857–5868. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yi R, Li Y, Wang FL, Miao G, Qi RM and
Zhao YY: MicroRNAs as diagnostic and prognostic biomarkers in
colorectal cancer. World J Gastrointest Oncol. 8:330–340. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hudson J, Duncavage E, Tamburrino A,
Salerno P, Xi L, Raffeld M, Moley J and Chernock RD: Overexpression
of miR-10a and miR-375 and downregulation of YAP1 in medullary
thyroid carcinoma. Exp Mol Pathol. 95:62–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shoshan E, Mobley AK, Braeuer RR, Kamiya
T, Huang L, Vasquez ME, Salameh A, Lee HJ, Kim SJ, Ivan C, et al:
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma
growth and metastasis. Nat Cell Biol. 17:311–321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu J, Zhang J, Li Y, Wang L, Sui B and
Dai D: MiR-455-5p acts as a novel tumor suppressor in gastric
cancer by down-regulating RAB18. Gene. 592:308–315. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hari DM, Leung AM, Lee JH, Sim MS, Vuong
B, Chiu CG and Bilchik AJ: AJCC Cancer Staging Manual 7th edition
criteria for colon cancer: Do the complex modifications improve
prognostic assessment? J Am Coll Surg. 217:181–190. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu S, Xie F, Wang H, Liu Z, Liu X, Sun L
and Niu Z: Ubenimex inhibits cell proliferation, migration and
invasion in renal cell carcinoma: The effect is
autophagy-associated. Oncol Rep. 33:1372–1380. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hirano S: Western blot analysis. Methods
Mol Biol. 926:87–97. 2014. View Article : Google Scholar
|
|
15
|
Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J,
Li K, Yu B, Li Z, Wang R, et al: Circulating microRNA-1 as a
potential novel biomarker for acute myocardial infarction. Biochem
Biophys Res Commun. 391:73–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao J, Cai J, Huang D, Han Q, Yang Q, Li
T, Ding H and Wang Z: miR-335 represents an invasion suppressor
gene in ovarian cancer by targeting Bcl-w. Oncol Rep. 30:701–706.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Niwa R and Slack FJ: The evolution of
animal microRNA function. Curr Opin Genet Dev. 17:145–150. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wightman B, Ha I and Ruvkun G:
Posttranscriptional regulation of the heterochronic gene lin-14 by
lin-4 mediates temporal pattern formation in C. elegans.
Cell. 75:855–862. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feinbaum R and Ambros V: The timing of
lin-4 RNA accumulation controls the timing of postembryonic
developmental events in Caenorhabditis elegans. Dev Biol.
210:87–95. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moss EG, Lee RC and Ambros V: The cold
shock domain protein LIN-28 controls developmental timing in C.
elegans and is regulated by the lin-4 RNA. Cell. 88:637–646.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rodriguez A, Vigorito E, Clare S, Warren
MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska
EA, et al: Requirement of bic/microRNA-155 for normal immune
function. Science. 316:608–611. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sand M, Skrygan M, Sand D, Georgas D, Hahn
SA, Gambichler T, Altmeyer P and Bechara FG: Expression of
microRNAs in basal cell carcinoma. Br J Dermatol. 167:847–855.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hummel R, Wang T, Watson DI, Michael MZ,
Van der Hoek M Haier J and Hussey DJ: Chemotherapy-induced
modification of microRNA expression in esophageal cancer. Oncol
Rep. 26:1011–1017. 2011.PubMed/NCBI
|
|
25
|
Bellissimo T, Russo E, Ganci F, Vico C,
Sacconi A, Longo F, Vitolo D, Anile M, Disio D, Marino M, et al:
Circulating miR-21-5p and miR-148a-3p as emerging non-invasive
biomarkers in thymic epithelial tumors. Cancer Biol Ther. 17:79–82.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang Q, Hou C, Huang D, Zhuang C, Jiang W,
Geng Z, Wang X and Hu L: miR-455-5p functions as a potential
oncogene by targeting galectin-9 in colon cancer. Oncol Lett.
13:1958–1964. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peeters M and Price T: Biologic therapies
in the metastatic colorectal cancer treatment continuum-applying
current evidence to clinical practice. Cancer Treat Rev.
38:397–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Morillas JD, Castells A, Oriol I, Pastor
A, Pérez-Segura P, Echevarría JM, Caballero B, González-Navarro A,
Bandrés F, Brullet E, et al: The Alliance for the prevention of
colorectal cancer in Spain. A civil commitment to society.
Gastroenterol Hepatol. 35:109–128. 2012.(In Spanish).
|
|
29
|
He K, Jin K, Wang H and Teng L:
Anti-angiogenic therapy for colorectal cancer: On the way to
getting better! Hepatogastroenterology. 59:1113–1117.
2012.PubMed/NCBI
|
|
30
|
Ng F, Ganeshan B, Kozarski R, Miles KA and
Goh V: Assessment of primary colorectal cancer heterogeneity by
using whole-tumor texture analysis: Contrast-enhanced CT texture as
a biomarker of 5-year survival. Radiology. 266:177–184. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Troiani T, Martinelli E, Orditura M, De
Vita F, Ciardiello F and Morgillo F: Beyond bevacizumab: New
anti-VEGF strategies in colorectal cancer. Expert opin Investig
Drugs. 21:949–959. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cizkova M, Vacher S, Meseure D, Trassard
M, Susini A, Mlcuchova D, Callens C, Rouleau E, Spyratos F,
Lidereau R and Bièche I: PIK3R1 underexpression is an independent
prognostic marker in breast cancer. BMC Cancer. 13:5452013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee SR, Kim SJ, Park Y, Sung HJ, Choi CW
and Kim BS: Bortezomib and melphalan as a conditioning regimen for
autologous stem cell transplantation in multiple myeloma. Korean J
Hema. 45:183–187. 2010. View Article : Google Scholar
|
|
34
|
Franke TF: PI3K/Akt: Getting it right
matters. Oncogene. 27:6473–6488. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bellacosa A, de Feo D, Godwin AK, Bell DW,
Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, et
al: Molecular alterations of the AKT2 oncogene in ovarian and
breast carcinomas. Int J Cancer. 64:280–285. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xie J, Chen Y, Meng F, Shu T, Liu Y, Zhang
L and Zhang ZX: Study on the relationship between the RASSF10 gene
and the biological behavior of hepatocellular carcinoma cells. Eur
Rev Med Pharmacol Sci. 21:3576–3580. 2017.PubMed/NCBI
|
|
37
|
Huang XP, Hou J, Shen XY, Huang CY, Zhang
XH, Xie YA and Luo XL: MicroRNA-486-5p, which is downregulated in
hepatocellular carcinoma, suppresses tumor growth by targeting
PIK3R1. FEBS J. 282:579–594. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kaur J and Sanyal SN: PI3-kinase/Wnt
association mediates COX-2/PGE(2) pathway to inhibit apoptosis in
early stages of colon carcinogenesis: Chemoprevention by
diclofenac. Tumour Biol. 31:623–631. 2010. View Article : Google Scholar : PubMed/NCBI
|
